Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gallo

Showing results (1311-1320 of 1,331) with videos related to

Pageof 134
Sort By:
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
Journal of the American College of Cardiology|April 12, 2023
Evolving Science on Cardiovascular Disease Among Hispanic/Latino Adults: JACC InternationalAmber Pirzada, Jianwen Cai, Gerardo Heiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancerM C Piccirillo, G Scambia, A Bologna, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.
Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.
Nature|March 3, 2017
The response of relativistic outflowing gas to the inner accretion disk of a black holeMichael L Parker, Ciro Pinto, Andrew C Fabian, et al.
ESMO Open|December 5, 2023
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Journal of Cancer Policy|October 6, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Pageof 134

Showing results (1311-1320 of 1,331) with videos related to

Sort By:
Pageof 134
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
Journal of the American College of Cardiology|April 12, 2023
Evolving Science on Cardiovascular Disease Among Hispanic/Latino Adults: JACC InternationalAmber Pirzada, Jianwen Cai, Gerardo Heiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancerM C Piccirillo, G Scambia, A Bologna, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.
Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.
Nature|March 3, 2017
The response of relativistic outflowing gas to the inner accretion disk of a black holeMichael L Parker, Ciro Pinto, Andrew C Fabian, et al.
ESMO Open|December 5, 2023
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Journal of Cancer Policy|October 6, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patientsL Arenare, C Porta, D Barberio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Pageof 134